|
US3598122A
(en)
*
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3797494A
(en)
*
|
1969-04-01 |
1974-03-19 |
Alza Corp |
Bandage for the administration of drug by controlled metering through microporous materials
|
|
US3731683A
(en)
*
|
1971-06-04 |
1973-05-08 |
Alza Corp |
Bandage for the controlled metering of topical drugs to the skin
|
|
US4144317A
(en)
*
|
1975-05-30 |
1979-03-13 |
Alza Corporation |
Device consisting of copolymer having acetoxy groups for delivering drugs
|
|
US4031894A
(en)
*
|
1975-12-08 |
1977-06-28 |
Alza Corporation |
Bandage for transdermally administering scopolamine to prevent nausea
|
|
US4201211A
(en)
*
|
1977-07-12 |
1980-05-06 |
Alza Corporation |
Therapeutic system for administering clonidine transdermally
|
|
US4286592A
(en)
*
|
1980-02-04 |
1981-09-01 |
Alza Corporation |
Therapeutic system for administering drugs to the skin
|
|
US4314557A
(en)
*
|
1980-05-19 |
1982-02-09 |
Alza Corporation |
Dissolution controlled active agent dispenser
|
|
US4327725A
(en)
*
|
1980-11-25 |
1982-05-04 |
Alza Corporation |
Osmotic device with hydrogel driving member
|
|
US4379454A
(en)
*
|
1981-02-17 |
1983-04-12 |
Alza Corporation |
Dosage for coadministering drug and percutaneous absorption enhancer
|
|
US4725272A
(en)
*
|
1981-06-29 |
1988-02-16 |
Alza Corporation |
Novel bandage for administering beneficial drug
|
|
US4849226A
(en)
*
|
1981-06-29 |
1989-07-18 |
Alza Corporation |
Method for increasing oxygen supply by administering vasodilator
|
|
US4435180A
(en)
*
|
1982-05-25 |
1984-03-06 |
Alza Corporation |
Elastomeric active agent delivery system and method of use
|
|
US4559222A
(en)
*
|
1983-05-04 |
1985-12-17 |
Alza Corporation |
Matrix composition for transdermal therapeutic system
|
|
US4783337A
(en)
*
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
|
US5082668A
(en)
*
|
1983-05-11 |
1992-01-21 |
Alza Corporation |
Controlled-release system with constant pushing source
|
|
US4612008A
(en)
*
|
1983-05-11 |
1986-09-16 |
Alza Corporation |
Osmotic device with dual thermodynamic activity
|
|
US4704282A
(en)
*
|
1984-06-29 |
1987-11-03 |
Alza Corporation |
Transdermal therapeutic system having improved delivery characteristics
|
|
US4588580B2
(en)
*
|
1984-07-23 |
1999-02-16 |
Alaz Corp |
Transdermal administration of fentanyl and device therefor
|
|
US4626539A
(en)
*
|
1984-08-10 |
1986-12-02 |
E. I. Dupont De Nemours And Company |
Trandermal delivery of opioids
|
|
US4573995A
(en)
*
|
1984-10-09 |
1986-03-04 |
Alza Corporation |
Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
|
|
US4568343A
(en)
*
|
1984-10-09 |
1986-02-04 |
Alza Corporation |
Skin permeation enhancer compositions
|
|
DE3572485D1
(en)
*
|
1984-12-22 |
1989-09-28 |
Thomae Gmbh Dr K |
Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
|
|
US4806341A
(en)
*
|
1985-02-25 |
1989-02-21 |
Rutgers, The State University Of New Jersey |
Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
|
|
US4645502A
(en)
*
|
1985-05-03 |
1987-02-24 |
Alza Corporation |
Transdermal delivery of highly ionized fat insoluble drugs
|
|
US4904475A
(en)
*
|
1985-05-03 |
1990-02-27 |
Alza Corporation |
Transdermal delivery of drugs from an aqueous reservoir
|
|
US4698062A
(en)
*
|
1985-10-30 |
1987-10-06 |
Alza Corporation |
Medical device for pulsatile transdermal delivery of biologically active agents
|
|
DE3775830D1
(de)
*
|
1986-06-13 |
1992-02-20 |
Alza Corp |
Aktivierung eines transdermalen drogenabgabesystems durch feuchtigkeit.
|
|
US4938759A
(en)
*
|
1986-09-02 |
1990-07-03 |
Alza Corporation |
Transdermal delivery device having a rate controlling adhesive
|
|
US4908027A
(en)
*
|
1986-09-12 |
1990-03-13 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
|
US5344656A
(en)
*
|
1986-09-12 |
1994-09-06 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
|
US4788062A
(en)
*
|
1987-02-26 |
1988-11-29 |
Alza Corporation |
Transdermal administration of progesterone, estradiol esters, and mixtures thereof
|
|
US4816258A
(en)
*
|
1987-02-26 |
1989-03-28 |
Alza Corporation |
Transdermal contraceptive formulations
|
|
US4943435A
(en)
*
|
1987-10-05 |
1990-07-24 |
Pharmetrix Corporation |
Prolonged activity nicotine patch
|
|
US4917895A
(en)
*
|
1987-11-02 |
1990-04-17 |
Alza Corporation |
Transdermal drug delivery device
|
|
US4781924A
(en)
*
|
1987-11-09 |
1988-11-01 |
Alza Corporation |
Transdermal drug delivery device
|
|
US5004610A
(en)
*
|
1988-06-14 |
1991-04-02 |
Alza Corporation |
Subsaturated nicotine transdermal therapeutic system
|
|
DE69009540T2
(de)
*
|
1989-03-15 |
1994-09-29 |
Nitto Denko Corp |
Arzneimittel enthaltendes Heftpflaster.
|
|
US5024843A
(en)
*
|
1989-09-05 |
1991-06-18 |
Alza Corporation |
Oral hypoglycemic glipizide granulation
|
|
US5591454A
(en)
*
|
1989-09-05 |
1997-01-07 |
Alza Corporation |
Method for lowering blood glucose
|
|
US5091190A
(en)
*
|
1989-09-05 |
1992-02-25 |
Alza Corporation |
Delivery system for administration blood-glucose lowering drug
|
|
DE3937271A1
(de)
*
|
1989-11-09 |
1991-05-16 |
Boehringer Ingelheim Kg |
Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
|
|
US5314694A
(en)
*
|
1990-10-29 |
1994-05-24 |
Alza Corporation |
Transdermal formulations, methods and devices
|
|
US5122382A
(en)
*
|
1990-10-29 |
1992-06-16 |
Alza Corporation |
Transdermal contraceptive formulations, methods and devices
|
|
FR2688138B1
(fr)
*
|
1992-03-06 |
1995-05-05 |
Rhone Poulenc Rorer Sa |
Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
|
|
ZA933349B
(en)
*
|
1992-05-13 |
1994-06-15 |
Alza Corp |
Transdermal administration of oxybutynin
|
|
US5442117A
(en)
*
|
1993-12-13 |
1995-08-15 |
Albemarle Corporation |
Enantiomeric resolution
|
|
US5635203A
(en)
*
|
1994-09-29 |
1997-06-03 |
Alza Corporation |
Transdermal device having decreased delamination
|
|
US5650420A
(en)
*
|
1994-12-15 |
1997-07-22 |
Pharmacia & Upjohn Company |
Pramipexole as a neuroprotective agent
|
|
US5674895A
(en)
*
|
1995-05-22 |
1997-10-07 |
Alza Corporation |
Dosage form comprising oxybutynin
|
|
US6262115B1
(en)
*
|
1995-05-22 |
2001-07-17 |
Alza Coporation |
Method for the management of incontinence
|
|
US5912268A
(en)
*
|
1995-05-22 |
1999-06-15 |
Alza Corporation |
Dosage form and method for treating incontinence
|
|
US6929801B2
(en)
*
|
1996-02-19 |
2005-08-16 |
Acrux Dds Pty Ltd |
Transdermal delivery of antiparkinson agents
|
|
US6919373B1
(en)
*
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
|
GB9705428D0
(en)
*
|
1997-03-15 |
1997-04-30 |
Knoll Ag |
Therapeutic agents
|
|
US5804215A
(en)
*
|
1997-03-21 |
1998-09-08 |
L. Perrigo Company |
Transdermal patch disposal system and method
|
|
US20010055613A1
(en)
*
|
1998-10-21 |
2001-12-27 |
Beth A. Burnside |
Oral pulsed dose drug delivery system
|
|
DE60007310D1
(de)
*
|
1999-06-04 |
2004-01-29 |
Elan Pharma Int Ltd |
Zusammensetzungen und methoden zur verhinderung des zelltods
|
|
US6480820B1
(en)
*
|
1999-09-20 |
2002-11-12 |
Advanced Cochlear Systems, Inc. |
Method of processing auditory data
|
|
US6750235B1
(en)
*
|
1999-09-30 |
2004-06-15 |
The General Hospital Corporation |
Pramipexole as a treatment for cocaine craving
|
|
US6443976B1
(en)
*
|
1999-11-30 |
2002-09-03 |
Akorn, Inc. |
Methods for treating conditions and illnesses associated with abnormal vasculature
|
|
JP2003523741A
(ja)
*
|
2000-02-01 |
2003-08-12 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
Ｂｃｌ−２様ポリヌクレオチド、ポリペプチドおよび抗体
|
|
US6955821B2
(en)
*
|
2000-04-28 |
2005-10-18 |
Adams Laboratories, Inc. |
Sustained release formulations of guaifenesin and additional drug ingredients
|
|
US6598123B1
(en)
*
|
2000-06-28 |
2003-07-22 |
Intel Corporation |
Snoop filter line replacement for reduction of back invalidates in multi-node architectures
|
|
ES2187249B1
(es)
*
|
2000-09-18 |
2004-09-16 |
Synthon Bv |
Procedimiento para la preparacion de 2-amino-6-(alquil)amino-4,5,6,7-tetrahidrobenzotiazoles.
|
|
US20020177626A1
(en)
*
|
2001-01-19 |
2002-11-28 |
Cook Graham D. |
Treatment of sleep disturbances
|
|
DE60231386D1
(de)
*
|
2001-04-09 |
2009-04-16 |
Neurosearch As |
Adenosin-a2a-rezeptor-antagonisten in kombination mit verbindungen mit neurotrophischer aktivität bei der behandlung von morbus parkinson
|
|
GB0117618D0
(en)
*
|
2001-07-19 |
2001-09-12 |
Phoqus Ltd |
Pharmaceutical dosage form
|
|
US20060281797A1
(en)
*
|
2001-12-11 |
2006-12-14 |
University Of Virginia Patent Foundation |
Neurorestoration with R(+) Pramipexole
|
|
ES2432527T3
(es)
*
|
2001-12-11 |
2013-12-04 |
University Of Virginia Patent Foundation |
Uso de pramipexol para tratar la esclerosis lateral amiotrófica
|
|
BR0215514A
(pt)
*
|
2002-01-16 |
2004-12-21 |
Boehringer Ingelheim Pharma |
Comprimido farmacêutico de bicamada compreendendo telmisartan e um diurético e preparação deste
|
|
US20050226926A1
(en)
*
|
2002-07-25 |
2005-10-13 |
Pfizer Inc |
Sustained-release tablet composition of pramipexole
|
|
US20050074865A1
(en)
*
|
2002-08-27 |
2005-04-07 |
Compound Therapeutics, Inc. |
Adzymes and uses thereof
|
|
GB0221513D0
(en)
*
|
2002-09-17 |
2002-10-23 |
Generics Uk Ltd |
Novel compounds and processes
|
|
PT1610791E
(pt)
*
|
2003-03-31 |
2011-05-23 |
Titan Pharmaceuticals Inc |
Dispositivo polim?rico implant?vel para liberta??o sustentada de agonista da dopamina
|
|
US7365086B2
(en)
*
|
2003-07-25 |
2008-04-29 |
Synthon Ip Inc. |
Pramipexole acid addition salts
|
|
US20080020028A1
(en)
*
|
2003-08-20 |
2008-01-24 |
Euro-Celtique S.A. |
Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
|
|
US20050053649A1
(en)
*
|
2003-09-08 |
2005-03-10 |
Anne-Marie Chalmers |
Medication delivery device
|
|
US20050220877A1
(en)
*
|
2004-03-31 |
2005-10-06 |
Patel Ashish A |
Bilayer tablet comprising an antihistamine and a decongestant
|
|
EP1773793A2
(en)
*
|
2004-07-03 |
2007-04-18 |
Merck Generics (UK) Limited |
Process for the preparation of pramipexole by chiral chromatography
|
|
CN101022788B
(zh)
*
|
2004-08-13 |
2010-11-10 |
贝林格尔·英格海姆国际有限公司 |
包含普拉克索或其可药用盐的延长释放小球制剂、其制备方法及其用途
|
|
DE102004044578A1
(de)
*
|
2004-09-13 |
2006-03-30 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System mit einer Haftschicht, Verfahren zum Silikonisieren einer Rückschicht des Systems und Verwendung der Rückschicht
|
|
US20060069263A1
(en)
*
|
2004-09-30 |
2006-03-30 |
Irina Gribun |
Process for the reduction of (S)-2-amino-6-propionamido-4,5,6,7-tetrahydrobenzo-thiazole
|
|
ME01615B
(me)
*
|
2004-11-05 |
2014-09-20 |
Boehringer Ingelheim Int |
Dvoslojna tableta koja sadrži telmisartan i amlodipin
|
|
WO2006070406A1
(en)
*
|
2004-12-29 |
2006-07-06 |
J.B. Chemicals & Pharmaceuticals Ltd |
Bilayer tablets of oxcarbazepine for controlled delivery and a process of preparation thereof
|
|
ES2310146B1
(es)
*
|
2004-12-30 |
2009-11-11 |
Chemagis Ltd. |
Nuevo procedimiento para preparar pramipexol y su mezcla isomerica optica mediante reduccion con triacetoxiborohidruro de sodio.
|
|
ATE444750T1
(de)
*
|
2005-08-15 |
2009-10-15 |
Univ Virginia |
Neurorestauration mit r(+) pramipexol
|
|
US20070203209A1
(en)
*
|
2005-08-18 |
2007-08-30 |
Wilmin Bartolini |
Useful indole compounds
|
|
CA2625341A1
(en)
*
|
2005-10-18 |
2007-04-26 |
Ono Pharmaceutical Co., Ltd. |
Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis
|
|
US8518926B2
(en)
*
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
|
US20070259930A1
(en)
*
|
2006-04-10 |
2007-11-08 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
|
ATE537826T1
(de)
*
|
2006-05-16 |
2012-01-15 |
Knopp Neurosciences Inc |
Zusammensetzungen aus r(+)- und s(-)-pramipexol sowie verfahren zu ihrer anwendung
|
|
WO2008042611A2
(en)
*
|
2006-09-29 |
2008-04-10 |
Centocor, Inc. |
Method of using il6 antagonists with mitoxantrone for prostate cancer
|
|
CN104107177A
(zh)
*
|
2006-12-14 |
2014-10-22 |
诺普生物科学有限责任公司 |
(r)-普拉克索的组合物以及使用该组合物的方法
|
|
US8524695B2
(en)
*
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
|
EP2136638A4
(en)
*
|
2007-03-14 |
2010-05-12 |
Knopp Neurosciences Inc |
MODIFIED RELEASE FORMULATIONS OF (6R) -4,5,6,7-TETRAHYDRO-N6-PROPYL-2,6-BENZOTHIAZOLE DIAMINE AND METHODS OF USE THEREOF
|
|
JP2010521496A
(ja)
*
|
2007-03-14 |
2010-06-24 |
ノップ ニューロサイエンシーズ、インク． |
キラル精製置換ベンゾチアゾールジアミンの合成
|